Medicalgorithmics Q1 2024 Investor Presentation

Medicalgorithmics investor presentation covering Q1 2024 financial results, strategy execution, and the functional integration of MDG with Kardiolytics. The presentation outlines growth strategy and outlook for 2024 following BioFund investment.